Products for Research Use Only
RegisterLogin

HL23

CAT: 0013-GTR19218694-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19218694-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HL23 is a histone deacetylase inhibitor for research into hepatocellular carcinoma (HCC) . It upregulates TXNIP expression, inducing potassium deficiency and impeding HCC progression in vitro and in vivo. HL23 also shows synergistic anti-tumor activity when combined with Sorafenib.
CAS Number
1448355-15-4
Field of Research
Epigenetics & Chromatin, Molecular Biology
Smiles
O (C (=O) C1=CC=CC=C1) C2=C3C=4[C@] (CC=5C=C (C (OC) =CC5) OC=6C=CC (C[C@]7 (C8=CC (O3) =C (OC) C=C8CCN7C) [H]) =CC6) (N (C) CCC4C=C2OC) [H]
Molecular Formula
C44H44N2O7
Molecular Weight
712.83
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19250519-01HL22
GTR19113286-01HL2-m5
GTR17858700Anti-CD22 [hL22 (Epratuzumab) ]
GTR17858699Anti-CD22 [hL22 (Epratuzumab) ]

Alternative Products

CatalogName
MBS5821069HL23
A24024-10HL23 10mg
A24024-50HL23 50mg
A24024-100HL23 100mg
A24024-5HL23 5mg

Popular Products